158 related articles for article (PubMed ID: 7689812)
1. Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation.
Mollison KW; Fey TA; Krause RA; Thomas VA; Mehta AP; Luly JR
Ann N Y Acad Sci; 1993 Jun; 685():55-7. PubMed ID: 7689812
[No Abstract] [Full Text] [Related]
2. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J
Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698
[No Abstract] [Full Text] [Related]
3. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Morris RE
Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
[No Abstract] [Full Text] [Related]
4. Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse.
Chen H; Qi S; Xu D; Fitzsimmons WE; Bekersky I; Sehgal SN; Daloze P
Transplant Proc; 1998 Sep; 30(6):2579-81. PubMed ID: 9745497
[No Abstract] [Full Text] [Related]
5. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
6. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
7. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
[No Abstract] [Full Text] [Related]
8. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
[No Abstract] [Full Text] [Related]
9. The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.
Francavilla A; Starzl TE; Carr B; Azzarone A; Carrieri G; Zeng QH; Porter KA
Transplant Proc; 1991 Dec; 23(6):2817-20. PubMed ID: 1721287
[No Abstract] [Full Text] [Related]
10. Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats.
Fabian MA; Denning SM; Bollinger RR
Transplant Proc; 1992 Jun; 24(3):1174. PubMed ID: 1604575
[No Abstract] [Full Text] [Related]
11. A modification of the in vivo mixed lymphocyte reaction and rapamycin's effect in this model.
Warner LM; Adams LM; Chang JY; Sehgal SN
Clin Immunol Immunopathol; 1992 Sep; 64(3):242-7. PubMed ID: 1386564
[TBL] [Abstract][Full Text] [Related]
12. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
Morris RE; Wu J; Shorthouse R
Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
[No Abstract] [Full Text] [Related]
13. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
14. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth.
Iwabuchi T; Maruyama T; Sei Y; Adachi K
J Dermatol Sci; 1995 Jan; 9(1):64-9. PubMed ID: 7537082
[TBL] [Abstract][Full Text] [Related]
16. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
Pelekanou V; Trezise AE; Moore AL; Kay JE
Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
[No Abstract] [Full Text] [Related]
17. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
18. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
[No Abstract] [Full Text] [Related]
19. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
20. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
